IVUS in Every Step of Complex Angioplasty

Complex angioplasties require not only experience and patience but also technology. Imaging–guided pre-dilation, stent sizing, and post-dilation reduced the cardiovascular events after a 3-year follow-up in patients who received drug-eluting stents in complex angioplasties.

El uso del ultrasonido intravascular en la angioplastia de tronco no protegido se asocia con mejores resultados en comparación con la angioplastia guiada solo por angiografía.

This paper, recently published in JACC Interventions, compared the 3-year outcome of the complex angioplasty optimization technique with intravascular imaging to “customize” every step of the procedure.

Researchers evaluated 9,525 patients from the IRIS-DES (Interventional Cardiology Research In-cooperation Society-Drug-Eluting Stents) registry who underwent angioplasty in the left main coronary artery, bifurcation lesions, long or diffuse (>30mm) lesions, or severe calcification. Intravascular ultrasound (IVUS) was used in 89.5% of patients (n = 8522).

IVUS was conducted in every step of the procedure (pre-dilation, stent sizing, and post-dilation) for just over a third of patients (35.4%) This subgroup was defined as the optimized complex angioplasty arm.


Read also: IVUS in Unprotected LMCA Angioplasty: Should We Change the Way We Use It?


After 3 years of follow-up, those who underwent optimized angioplasty had a significantly lower risk of suffering adverse events (5.6% vs. 7.9%; hazard ratio [HR]: 0.71; 95% confidence interval [CI]: 0.63 to 0.81; p < 0.001).

This difference was significant, even when IVUS was used in the rest of the population in at least one step of the procedure.

These results confirm data from the ULTIMATE and the IVUS-XPL.

Conclusion

Patients who undergo complex coronary angioplasty where IVUS is performed in every step of the procedure experience fewer adverse events after 3-years of follow-up. All-step optimization should be actively applied in routine practice.

Original Title: Optimal Stenting Technique for Complex Coronary Lesions. Intracoronary Imaging-Guided Pre-Dilation, Stent Sizing, and Post-Dilation.

Reference: Hanbit Park et al. J Am Coll Cardiol Intv 2020;13:1403–13. https://doi.org/10.1016/j.jcin.2020.03.023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...